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Background
• Increased body fat, obesity, and prediabetes are all
linked to increased risk of cancers in
postmenopausal women
• Excess fat can create inflammatory environment > tumor cell invasion and proliferation1
• Visceral fat in particular is known to cause adipose
tissue dysfunctionality leading to inflammation2
• Adiponectin (APN) is a protein with antiinflammatory, antiproliferative, and proapoptotic
properties
• decreased in women with obesity
• potentially a link between obesity and cancer
risk3

Results Continued

Results

Tables Detailing Results from Multiple Regression Controlling
for Participant BMI

Demographics of Study Participants
Race (Black/White/Other)
Ethnicity (Hispanic/Non-Hispanic)

N

%

12 / 15 / 2

41.1 / 51.7 / 6.8

5 / 24

17.2 / 82.8

Scatter Plot showing Correlation between Adiponectin
Levels and Visceral Fat Area

Model Summary
Model

R

R Square

1
2

.072a
.353b

.005
.125

a.
b.

Adjusted R
Square
-.038
.000

Std. Error of F Value
the Estimate
4.996
.119
4.904
.998

Significance
(P Value)
.773a
.413b

Predictors: (Constant), BODY_MASS_INDEX.1
Predictors: (Constant), BODY_MASS_INDEX.1, VFAT_AREA.1, SUBQFAT_MASS.1.

Research Question
Multiple Regression does not give statistically significant prediction of
APN levels. None of the variables on their own are statistically significant.

Circulating level of APN is inversely correlated
with obesity, but… can it be correlated with
specific types of fat?

Objective: determine whether visceral fat (around
the internal organs and along the muscle wall) or
subcutaneous fat (just beneath the skin) are
correlated with APN levels

Methods

Discussion
•

Scatter Plot showing Correlation between Adiponectin Levels
and Subcutaneous Fat Mass

Secondary analysis of baseline data from 26
postmenopausal women with obesity (body
mass index >30) from a randomized biomarker
study of metformin and lifestyle intervention.4
• Adiponectin was measured using routine
clinical testing procedures after a fasting
blood draw
• Visceral fat area was estimated from Dual
Energy X-Ray Absorptiometry Scan (Hologic
Discovery W QDR DXA system,Waltham, MA).

• Approximated subcutaneous fat mass by
subtracting visceral fat mass from total fat
mass
Data analysis:
Correlation test: to test associations between
adiponectin and subcutaneous fat and visceral
fat
Multiple Regression: to determine if
subcutaneous fat and visceral fat can predict
adiponectin levels when controlling for
participant body mass index

Visceral fat area and subcutaneous fat mass cannot be used to
predict APN levels in post-menopausal women who are obese and
have pre-diabetes
• Neither the correlation between APN and visceral fat nor the
correlation between APN and subcutaneous fat is significant
Limitations of the data available:
- Subcutaneous fat mass is an estimation and includes intramuscular
fat
- Data doesn’t include full range of BMI (obese women only) and
thus association between adiposity and APN may be reduced
- Limited sample size
Future Directions:
- More investigation is needed to determine if there is a connection
between visceral fat or subcutaneous fat and APN
- Consider using data with larger sample size to account for smaller
range and thus, try for statistically significant results
Responsible
Relation to CancerConduct
Prevention: of Research
- Further investigation into they type of fat associated with
biomarkers of cancer risk such as APN can direct interventions in
high risk people, potentially increasing the effectiveness of these
interventions
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Binary Correlation of Visceral and Subcutaneous Fat
with Adiponectin
Correlation to APN
Visceral Fat (n=25)
-.178
Subcutaneous Fat (n=25) .098

Significance
.395
.640

Neither correlation is significant, but visceral fat is weakly negatively
correlated with APN while subcutaneous fat is not correlated with
APN.
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